{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T07:33:04Z","timestamp":1769153584504,"version":"3.49.0"},"reference-count":10,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2023.1188945","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T11:29:05Z","timestamp":1680780545000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Editorial: Therapeutic modulators inhibiting neuromuscular and motor neuron degeneration"],"prefix":"10.3389","volume":"17","author":[{"given":"Sidharth","family":"Mehan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2174\/1566524020666200427214356","article-title":"Exploring molecular approaches in amyotrophic lateral sclerosis: drug targets from clinical and pre-clinical findings","volume":"14","author":"Alam","year":"2021","journal-title":"Curr. Mol. Pharmacol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2174\/1570163817666200207100903","article-title":"Neuroprotective methodologies in the treatment of multiple sclerosis current status of clinical and pre-clinical findings. Curr","volume":"18","author":"Kapoor","year":"2021","journal-title":"Drug. Discov. Technol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2174\/1874467214666210301121432","article-title":"Connection between JAK\/STAT and PPAR\u03b3, signaling during the progression of multiple sclerosis: insights into the modulation of t-cells and immune responses in the brain","volume":"14","author":"Kumar","year":"2021","journal-title":"Curr. Mol. Pharmacol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00109-022-02272-6","article-title":"Therapeutic modulation of JAK-STAT, mTOR, and PPAR-\u03b3 signaling in neurological dysfunctions","volume":"101","author":"Kumar","year":"2023","journal-title":"J. Mol. Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1007\/s11064-021-03366-2","article-title":"Nrf2\/HO-1 signaling activator acetyl-11-keto-beta boswellic acid (AKBA)-mediated neuroprotection in methyl mercury-induced experimental model of ALS","volume":"46","author":"Minj","year":"","journal-title":"Neurochem. Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"630","DOI":"10.2174\/1566524021666210111104920","article-title":"Targeting abnormal Nrf2\/HO-1 signaling in amyotrophic lateral sclerosis: current insights on drug, targets, and influences on neurological, disorders","volume":"21","author":"Minj","year":"","journal-title":"Curr. Mol. Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.3390\/molecules27123878","article-title":"Activation of IGF 1\/GLP-1 signalling via 4-hydroxyisoleucine prevents motor neuron impairments in experimental ALS rats exposed to methylmercury-induced neurotoxicity","volume":"27","author":"Shandilya","year":"2022","journal-title":"Molecules"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.phyplu.2021.100139","article-title":"Understanding abnormal c-JNK\/p38MAPK signaling overactivation involved in the progression of multiple sclerosis: possible therapeutic targets and impact on neurodegenerative diseases","volume":"39","author":"Singh","year":"2021","journal-title":"Neurotox. Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.3390\/genes13081324","article-title":"Nrf2\/HO-1 signaling stimulation through acetyl-11-keto-beta-boswellic acid (AKBA) provides neuroprotection in ethidium bromide-induced experimental model of multiple sclerosis","volume":"13","author":"Upadhayay","year":"2022","journal-title":"Genes"},{"key":"B10","doi-asserted-by":"publisher","first-page":"9603271221084276","DOI":"10.1177\/09603271221084276","article-title":"Protective effects of apigenin on methylmercury-induced behavioral\/neurochemical abnormalities and neurotoxicity in rats","volume":"41","author":"Yadav","year":"2022","journal-title":"Hum. Exp. Toxicol"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1188945\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T11:29:08Z","timestamp":1680780548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1188945\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,6]]},"references-count":10,"alternative-id":["10.3389\/fnins.2023.1188945"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2023.1188945","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,6]]},"article-number":"1188945"}}